StonvexLoading…
StonvexStonvexStonvexCore line items from HST's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $6.11B | $5.68B | $5.31B | $4.91B |
Operating Income | $855.00M | $875.00M | $827.00M | $775.00M |
Net Income | $765.00M | $697.00M | $740.00M | $633.00M |
EPS (Diluted) | $1.10 | $0.99 | $1.04 | $0.88 |
Total Assets | $13.05B | $13.05B | $12.24B | $12.27B |
Total Liabilities | $6.32B | $6.27B | $5.42B | $5.39B |
Cash & Equivalents | $768.00M | $554.00M | $1.14B | $667.00M |
Free Cash Flow OCF − CapEx | $1.23B | $1.24B | $1.25B | $1.11B |
Shares Outstanding | 687.80M | 699.10M | 703.60M | 713.40M |